Impact of molecular breast cancer portraits on new treatment strategies for gynecologic malignancies

Current Opinion in Obstetrics and Gynecology

Volumn 25, Issue 1, 2013, Pages 38-39

  Konecny, Gottfried E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; LAPATINIB; TAMOXIFEN; TRASTUZUMAB;

ANGIOGENESIS; BREAST CANCER; CANCER SURGERY; DNA METHYLATION; DNA REPAIR; EDITORIAL; ENDOMETRIUM CANCER; GYNECOLOGIC CANCER; HUMAN; MOLECULARLY TARGETED THERAPY; OVARY CANCER; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT RESPONSE; UTERINE CERVIX CANCER;

BREAST NEOPLASMS; FEMALE; GENITAL NEOPLASMS, FEMALE; HUMANS;

EID: 84873081788     PISSN: 1040872X     EISSN: 1473656X     Source Type: Journal    
DOI: 10.1097/GCO.0b013e32835c5e36     Document Type: Editorial

References (12)

1. Barnholtz-Sloan JS, Schwartz AG, Qureshi F, et al. Ovarian cancer: changes in patterns at diagnosis and relative survival over the last three decades. Am J Obstet Gynecol 2003; 189:1120-1127.
2. http://www.cancer.org/Cancer/OvarianCancer/DetailedGuide/ ovarian-cancerkey-statistics. Accessed November 2012.
3. http://seer.cancer.gov/csr/1975-2008/results-merged/topic-prevcounts. pdf. Accessed November 2012.
4. http://seer.cancer.gov/faststats. Accessed November 2012.
5. Office for National Statistics Mortality Statistics: deaths registered in 2010, England and Wales 2010, National Statistics: London.
6. Autier P, Boniol M, Gavin A, et al. Breast cancer mortality in neighbouring European countries with different levels of screening but similar access to treatment: trend analysis of WHO mortality database. Br Med J 2011; 343:d4411.
7. Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature 2012; 490:61-70.
8. Shastry M, Yardley DA. Updates in the treatment of basal/triple-negative breast cancer. Curr Opin Obstet Gynecol 2013; 25:40-48.
9. Howell SJ. Advances in the treatment of luminal breast cancer. Curr Opin Obstet Gynecol 2013; 25:49-54.
10. Konecny GE. Emerging strategies for the dual inhibition of HER2-positive breast cancer. Curr Opin Obstet Gynecol 2013; 25:55-65.
11. von Minckwitz G, Untch M, Loibl S. Update on neoadjuvant/preoperative therapy of breast cancer: experiences from the German Breast Group. Curr Opin Obstet Gynecol 2013; 25:66-73.
12. Karam A. Update on breast cancer surgery approaches. Curr Opin Obstet Gynecol 2013; 25:74-80.